SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Javier Romero-Otero, Borja García-Gómez, José M Duarte-Ojeda, Alfredo Rodríguez-Antolín, Antoni Vilaseca, Sigrid V Carlsson, Karim A Touijer, Active surveillance for prostate cancer, International Journal of Urology, 2016, 23, 2
  2. 2
    Chiranjeev Sanyal, Armen G. Aprikian, Fabio L. Cury, Simone Chevalier, Alice Dragomir, Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis, Cancer, 2016, 122, 4
  3. 3
    Ahmed Haddad, Yair Lotan, Prostate Cancer, 2016,

    CrossRef

  4. 4
    Frederik B. Thomsen, Kasper D. Berg, M. Andreas Røder, Peter Iversen, Klaus Brasso, Active surveillance for localized prostate cancer: An analysis of patient contacts and utilization of healthcare resources, Scandinavian Journal of Urology, 2015, 49, 1, 43

    CrossRef

  5. 5
    Lindsay Yuh, Marc A. Dall’Era, David F. Penson, Christopher P. Evans, Active Surveillance for Prostate Cancer under the Patient Protection and Affordable Care Act, Urology Practice, 2015, 2, 4, 154

    CrossRef

  6. You have free access to this content6
    Max Kates, Jeffrey J. Tosoian, Bruce J. Trock, Zhaoyong Feng, H. Ballentine Carter, Alan W. Partin, Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols, BJU International, 2015, 115, 2
  7. 7
    Christopher M. Deibert, Max Kates, James M. McKiernan, Benjamin A. Spencer, National estimated costs of never events following radical prostatectomy, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 9, 385.e1

    CrossRef

  8. 8
    A. Dragomir, F. L. Cury, A. G. Aprikian, Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison, CMAJ Open, 2014, 2, 2, E60

    CrossRef

  9. 9
    Reka Pataky, Roman Gulati, Ruth Etzioni, Peter Black, Kim N. Chi, Andrew J. Coldman, Tom Pickles, Scott Tyldesley, Stuart Peacock, Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada, International Journal of Cancer, 2014, 135, 4
  10. 10
    Florian Koerber, Raphaela Waidelich, Björn Stollenwerk, Wolf Rogowski, The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer, BMC Health Services Research, 2014, 14, 1, 163

    CrossRef

  11. 11
    Jeffrey M. Martin, Elizabeth A. Handorf, Alexander Kutikov, Robert G. Uzzo, Justin E. Bekelman, Eric M. Horwitz, Marc C. Smaldone, The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base, Cancer, 2014, 120, 14
  12. 12
    Karim Chamie, Geoffrey A. Sonn, David S. Finley, Nelly Tan, Daniel J.A. Margolis, Steven S. Raman, Shyam Natarajan, Jiaoti Huang, Robert E. Reiter, The Role of Magnetic Resonance Imaging in Delineating Clinically Significant Prostate Cancer, Urology, 2014, 83, 2, 369

    CrossRef

  13. 13
    Feng Xie, Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?, European Urology, 2013, 63, 2, 411

    CrossRef

  14. 14
    David Gabriel Alonzo, Amanda Lynne Mure, Mark S. Soloway, Prostate Cancer and the Increasing Role of Active Surveillance, Postgraduate Medicine, 2013, 125, 5, 109

    CrossRef

  15. 15
    Kristalee Watson, Cheng Wang, Asli Yilmaz, Tarek A. Bismar, Kiril Trpkov, Use of Immunohistochemistry in Routine Workup of Prostate Needle Biopsies: A Tertiary Academic Institution Experience, Archives of Pathology & Laboratory Medicine, 2013, 137, 4, 541

    CrossRef

  16. 16
    Peter Whelan, The Long Perspective: Prostate Cancer as a Chronic Disease,